%0 Journal Article
%T Original research article: Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
%A Amra Jujic
%A Andreas Bergmann
%A Erasmus Bachus
%A Giada Zoccoli
%A Joachim Struck
%A John Molvin
%A Martin Magnusson
%A Oliver Hartmann
%A Olle Melander
%A Salvatore Di Somma
%A Silvia Navarin
%J Archive of "Open Heart".
%D 2019
%R 10.1136/openhrt-2019-001048
%X In an acute heart failure (AHF) setting, proenkephalin A 119¨C159 (penKid) has emerged as a promising prognostic marker for predicting worsening renal function (WRF), while bioactive adrenomedullin (bio-ADM) has been proposed as a potential marker for congestion. We examined the diagnostic value of bio-ADM in congestion and penKid in WRF and investigated the prognostic value of bio-ADM and penKid regarding mortality, rehospitalisation and length of hospital stay in two separate European AHF cohorts
%K bioactive adrenomedullin
%K proenkephalin
%K acute heart failure
%K congestion
%K worsening renal function
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615850/